These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 28964792)

  • 41. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
    Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
    Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
    Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
    J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma.
    Ahn S; Hyeon J; Park CK
    Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):286-94. PubMed ID: 23742774
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of postoperative TACE on prognosis of HCC with microscopic venous invasion.
    Ke-Wei L; Tian-Fu W; Xi L; Lü-Nan Y; Bo L; Yong Z; Wu-Sheng L; Wen-Tao W; Ming-Qing X; Jia-Yin Y; Yu-Kui M; Zhe-Yu C
    Hepatogastroenterology; 2012 Sep; 59(118):1944-6. PubMed ID: 22246191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases.
    Schmitz KJ; Sotiropoulos GC; Baba HA; Schmid KW; Müller D; Paul A; Auer T; Gamerith G; Loeffler-Ragg J
    Liver Int; 2011 Jul; 31(6):810-6. PubMed ID: 21645211
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Model based on γ-glutamyltransferase and alkaline phosphatase for hepatocellular carcinoma prognosis.
    Xu XS; Wan Y; Song SD; Chen W; Miao RC; Zhou YY; Zhang LQ; Qu K; Liu SN; Zhang YL; Dong YF; Liu C
    World J Gastroenterol; 2014 Aug; 20(31):10944-52. PubMed ID: 25152598
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma.
    Ohno A; Yorita K; Haruyama Y; Kondo K; Kato A; Ohtomo T; Kawaguchi M; Marutuska K; Chijiiwa K; Kataoka H
    Liver Int; 2014 Jul; 34(6):942-52. PubMed ID: 24433439
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MEP1A contributes to tumor progression and predicts poor clinical outcome in human hepatocellular carcinoma.
    OuYang HY; Xu J; Luo J; Zou RH; Chen K; Le Y; Zhang YF; Wei W; Guo RP; Shi M
    Hepatology; 2016 Apr; 63(4):1227-39. PubMed ID: 26660154
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma.
    Zhang DZ; Wei XD; Wang XP
    World J Gastroenterol; 2015 Apr; 21(15):4635-43. PubMed ID: 25914473
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
    Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
    J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression Pattern and Clinical Significance of Gab2 Protein in Hepatocellular Carcinoma.
    Hu X; He B; Zhou L; Xie H; Zheng S
    Clin Lab; 2016; 62(6):1087-92. PubMed ID: 27544933
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High NEK2 Expression Is a Predictor of Tumor Recurrence in Hepatocellular Carcinoma Patients After Hepatectomy.
    Wubetu GY; Morine Y; Teraoku H; Yoshikawa M; Ishikawa D; Yamada S; Ikemoto T; Saito YU; Imura S; Shimada M
    Anticancer Res; 2016 Feb; 36(2):757-62. PubMed ID: 26851035
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overexpression of NAD(P)H: Quinone Oxidoreductase 1 Inhibits Hepatocellular Carcinoma Cell Proliferation and Induced Apoptosis by Activating AMPK/PGC-1α Pathway.
    Zhang X; Han K; Yuan DH; Meng CY
    DNA Cell Biol; 2017 Apr; 36(4):256-263. PubMed ID: 28191864
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NAD(P)H: Quinone oxidoreductase 1 overexpression in hepatocellular carcinoma potentiates apoptosis evasion through regulating stabilization of X-linked inhibitor of apoptosis protein.
    Li WY; Zhou HZ; Chen Y; Cai XF; Tang H; Ren JH; Wai Wong VK; Kwan Law BY; Chen Y; Cheng ST; Yu HB; Cai HY; Chen WX; Tang N; Zhang WL; Tao NN; Yang QX; Ren F; He L; Jiang H; Huang AL; Chen J
    Cancer Lett; 2019 Jun; 451():156-167. PubMed ID: 30867140
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of GRK2 and IGF1R in hepatocellular carcinoma: clinicopathological and prognostic significance.
    Lin SB; Zhou L; Liang ZY; Zhou WX; Jin Y
    J Clin Pathol; 2017 Sep; 70(9):754-759. PubMed ID: 28202495
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MAP Kinase-Interacting Kinase 1 Promotes Proliferation and Invasion of Hepatocellular Carcinoma and Is an Unfavorable Prognostic Biomarker.
    Wang X; Wang Y; Zhang Q; Zhuang H; Chen B
    Med Sci Monit; 2018 Mar; 24():1759-1767. PubMed ID: 29576605
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
    World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum and tissue vascular endothelial growth factor predicts prognosis in hepatocellular carcinoma patients after partial liver resection.
    Zhong C; Wei W; Su XK; Li HD; Xu FB; Guo RP
    Hepatogastroenterology; 2012; 59(113):93-7. PubMed ID: 22251524
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tissue microarray-based study of hepatocellular carcinoma validating SPIB as potential clinical prognostic marker.
    Ho YJ; Lin YM; Huang YC; Yeh KT; Lin LI; Lu JW
    Acta Histochem; 2016 Jan; 118(1):38-45. PubMed ID: 26610895
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High expression of N-acetyltransferase 10: a novel independent prognostic marker of worse outcome in patients with hepatocellular carcinoma.
    Zhang X; Liu J; Yan S; Huang K; Bai Y; Zheng S
    Int J Clin Exp Pathol; 2015; 8(11):14765-71. PubMed ID: 26823802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.